Hedy Kindler to Antibodies, Bispecific
This is a "connection" page, showing publications Hedy Kindler has written about Antibodies, Bispecific.
Connection Strength
0.195
-
Phase I study of ABBV-428, a mesothelin-CD40 bispecific, in patients with advanced solid tumors. J Immunother Cancer. 2021 02; 9(2).
Score: 0.195